Abstract

Keywords: Eroin, Esrar, Gebelik, Neonatal yoksunluk sendromu

References

  1. 1. Kocherlakota P. Neonatal Abstinence Syndrome. Pediatrics
  2. 2014;134:e547–61.
  3. 2. Tolia VN, Patrick SW, Bennett MM. Increasing incidence of the
  4. neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J
  5. Med 2015; 372:2118-26.
  6. 3. Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse
  7. treatment linked with prenatal visits improves perinatal outcomes:
  8. A new standard. J Perinatol 2008; 28:597-603.
  9. 4. WHO. Guidelines for identification and management of substance
  10. use and substance use disorders in pregnancy World Health
  11. Organization. 2014:224.
  12. 5. Weaver MF. Perinatal addiction. In: Graham AW, Shultz TK (eds),
  13. Principles of Addiction Medicine, 3rd ed. American Society of
  14. Addiction Medicine, 2003:1231.
  15. 6. Wong S, Ordean A, Kahan M; Maternal Fetal Medicine Committee;
  16. Family Physicians Advisory Committee; Medico-Legal Committee;
  17. Ad Hoc Reviewers; Special Contributors. Substance use in
  18. pregnancy. J Obstet Gynaecol Can 2011;33:367-84.
  19. 7. Zahorec R. Ratio of neutrophil to lymphocyte counts- Rapid and
  20. simple parameter of systemic inflammation and stress n critically ill.
  21. Bratisl Lek Listy 2001; 102:5-14.
  22. 8. Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A.
  23. C-Reactive Protein and substance use disorders in adolescence
  24. and early adulthood: A prospective analysis. Drug Alcohol Depend
  25. 2013;133:712–7.
  26. 9. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal
  27. abstinence syndrome: Assessment and management. Addict Dis
  28. 1975;2:141–58.
  29. 10. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics
  30. 2012;129:540-60.
  31. 11. Bagley SM, Wachman EM, Holland E, Brogly SB. Review of the
  32. assessment and management of neonatal abstinence syndrome.
  33. Addict Sci Clin Pract 2014;9:19.
  34. 12. Tetstall E, Liu AJ, An EI, Canalese J, Nanan R. Pregnancy
  35. and neonatal characteristics of opioid-dependent Indigenous
  36. Australians: A rural and metropolitan comparison. Aust N Z J
  37. Obstet Gynaecol 2009;49: 279–84.
  38. 13. Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S,
  39. Rough K, Mogun H, et al. Risk of neonatal drug withdrawal after
  40. intrauterine co-exposure to opioids and psychotropic medications:
  41. Cohort study. BMJ 2017;358:3326.
  42. 14. Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff
  43. MA, et al. OCHNAS Consortium. A multicenter cohort study
  44. of treatments and hospital outcomes in neonatal abstinence
  45. syndrome. Pediatrics 2014;134:e527-34.
  46. 15. ACOG Committee on Practice Bulletins; Use of psychiatric
  47. medications during pregnancy and lactation. Obstet Gynecol
  48. 2008;111:1001–20.
  49. 16. Shainker SA, Saia K, Lee-Parritz A. Opioid addiction in pregnancy.
  50. Obstet Gynecol Surv 2012;67:817–25.
  51. 17. Behnke M, Eyler FD. The consequences of prenatal substance use
  52. for the developing fetus, newborn and young child. Int J Addict
  53. 1993;28:1341-91.
  54. 18. Grossman MR, Berkwitt AK, Osborn RR. An initiative to improve
  55. the quality of care of infants with neonatal abstinence syndrome.
  56. Pediatrics 2017;139:e20163360.
  57. 19. Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D, Lindow
  58. SW. Neonatal outcome following maternal opiate use in late
  59. pregnancy. Int J Obstet Gynaecol 2001;74:241-6.
  60. 20. Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al.
  61. The usefulness of C-reactive protein and neutrophil-to-lymphocyte
  62. ratio for predicting the outcome in hospitalized patients with liver
  63. cirrhosis. BMC Gastroenterol 2015;15:146.
  64. 21. Yazar FM, Bakacak M, Emre A, Urfalıoglu A, Serin S, Cengiz E,
  65. et al. Predictive role of neutrophil-to-lymphocyte and plateletto-
  66. lymphocyte ratios for diagnosis of acute appendicitis during
  67. pregnancy. Kaohsiung J Med Sci 2015;31:591-6.
  68. 22. Demir AK, Demirtas A, Kaya SU, Tastan I, Butun I, Sagcan M, et
  69. al. The relationship between the neutrophilelymphocyte ratio and
  70. disease activity in patients with ulcerative colitis. Kaohsiung J Med
  71. Sci 2015;31:585-90.
  72. 23. Özkan N, Sonmez MB, Durmus P Tas, Gorgulu Y, Cınar R
  73. Kose, Vardar ME. Elevated neutrophil lymphocyte ratio in
  74. patients with substance use disorders. European Psychiatry
  75. 2017;41:S872-S873.
  76. 24. Catal F, Tayman C, Tonbul A, Akça H, Kara S, Tatli MM, et al. Mean
  77. platelet volume (MPV) may simply predict the severity of sepsis in
  78. preterm infants. Clin Lab 2014;60:1193-200.
  79. 25. Witt CE, Rudd KE, Bhatraju P, Rivara FP, Hawes SE, Weiss NS.
  80. Neonatal abstinence syndrome and early childhood morbidity
  81. and mortality in Washington state: A retrospective cohort study.J
  82. Perinatol 2017;37:1124-9.
  83. 26. Povroznik JM, Engler-Chiurazzi, Nanavati T, Pergami P. Absolute
  84. lymphocyte and neutrophil counts in neonatal ischemic brain injury.
  85. SAGE Open Med 2018;6:2050312117752613.

Copyright and license

How to cite

1.
Tayman C. Evaluation of Neonatal Abstinence Syndrome (NAS) Frequency and Systemic Inflammatory Response in NAS. Turk J Pediatr Dis [Internet]. 2019 May 24 [cited 2025 May 24];13(3):171-6. Available from: https://turkjpediatrdis.org/article/view/609